PMDA — authorised 28 March 2022
- Marketing authorisation holder: Chugai Pharmaceutical Co., Ltd
- Status: approved
PMDA authorised Vabysmo on 28 March 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 28 March 2022.
Chugai Pharmaceutical Co., Ltd holds the Japanese marketing authorisation.